Cleveland, OH – May 26, 2026 – Checkpoint Surgical, Inc., a leader in intraoperative nerve care and regeneration, today announced it has achieved a Net Promoter Score (NPS) of 87, placing it among the elite tier of customer-centric organizations and reflecting its commitment to the surgeons and patients it serves.
The Net Promoter Score is a globally recognized metric that measures customer loyalty by gauging the likelihood of customers recommending a company’s products or services to others, scored on a scale of -100 to +100. Scores above 70 are considered world-class; while the average for the medical device industry is approximately 60.
In the medical device industry, NPS carries particular weight. Surgeons and clinicians make high-stakes decisions where trust in a device directly impacts patient outcomes, making their willingness to recommend a true measure of confidence.
“This score reflects the strong partnerships we’ve built with surgeons and hospital teams across the country,” said Derek Lewis, President & CEO of Checkpoint Surgical. “Our focus has always been on supporting clinicians with groundbreaking technology, education, and service so they can provide the best possible care for their patients. We’re grateful for the trust our customers place in us every day.”
Checkpoint Surgical continues to invest in surgeon education initiatives, post-market clinical research, and dedicated field support resources to help ensure customers receive both innovative technology and responsive service throughout the surgical continuum. These efforts are ultimately intended to support better surgical experiences and positive outcomes for patients.
The company plans to continue conducting annual NPS surveys as part of its commitment to continuous improvement and customer partnership, using customer feedback alongside clinical and business performance metrics to guide future growth and innovation.
About Checkpoint Surgical
Checkpoint Surgical is a privately held medical device company based in Cleveland, Ohio. The company works with surgeons to advance the science and practice of peripheral nerve care through research, education, and innovative product development. Checkpoint Surgical’s state-of-the-art nerve stimulation devices have become the standard of care for intraoperative nerve stimulation. The company is actively developing new products to enhance and support the entire continuum of intraoperative nerve care. For more information about Checkpoint Surgical, visit www.checkpointsurgical.com
0136-MKT-185-A
